Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2012

Feb 14, 2012

31523_dirs_2012-02-14_04218d85-6626-48a2-ab14-cdf74b0231b5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-12-31

Reporting Person: Crowley John F (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-16 Common Stock G 100000 $0.00 Disposed 9867 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100000 Indirect

Footnotes

F1: Mr. Crowley transferred 100,000 shares to the John F. Crowley 2011 GRAT f/b/o John F. Crowley.